Medical Crossfire®: Critical Conversations Between CAR T Centers of Excellence and the Oncology Community

Medical Crossfire®: Critical Conversations Between CAR T Centers of Excellence and the Oncology Community is organized by Physicians' Education Resource, LLC (PER).

Release Date: June 21, 2019
Expiration Date: June 21, 2020

Target Audience:
This educational program is directed toward oncologists and hematologists interested in the treatment and management of lymphoid malignancies with CAR T therapies. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with lymphoid malignancies will be invited to participate.

Accreditation/Credit Designation:
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Learning Objectives:
Upon successful completion of this educational program, you should be better prepared to:
• Realize the unique mechanistic characteristics of CAR T therapies that are important to manufacture and clinical use.
• Explain clinical trial data with CAR T therapy across hematologic malignancies.
• Understand pathways for identification of eligible patients, processes for referral to specialized treatment centers, and best practices for follow-up after treatment.
• Recognize the potential for CAR T treatment toxicities as well as best practices for detection, management, and mitigation of potential toxicities

 Additional details will be posted as soon as they are available.